Drug Kickback Scheme Sees Lawsuits Against Novartis and Lawsuit Settled Against Bioscrip
Suit Alleges Novartis Orchestrated a Kickback Scheme with Bioscrip, Inc., by Referring New Patients and Giving Rebates to BioScrip in Return for Bioscrip Increasing Refills of Exjade Prescriptions Through Biased Recommendations to Patients, Which Emphasized the Benefits of Refills While Understating Exjade’s Serious, Potentially Life-Threatening Side Effects BioScrip Agrees to Pay $15 Million
Drug Kickback Scheme Sees Lawsuits Against Novartis and Lawsuit Settled Against Bioscrip Read More »